Clinical Trial Location: Belgium

A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib (STOP-LTR)